微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 14.85% | -27.42% | 37.63% | 5/159 | 1.2% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 10.79% | -11.19% | 122.47% | 7/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 4.85% | -21.39% | -77.5% | 13/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 21.56% | 10.11% | 5.38% | 4/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 20.46% | 11.2% | 68.4% | 4/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 12.15% | 32.64% | 96.92% | 4/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 6.17% | 32.69% | -68.49% | 4/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 19.58% | 14.37% | 6.41% | 3/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 18.4% | 19.64% | 100.87% | 2/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 9.16% | -15.03% | 96.99% | 9/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 4.65% | -2.52% | -72.84% | 12/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 17.12% | -7.01% | 11.31% | 12/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 15.38% | -13.25% | 42.67% | 8/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 10.78% | -5.77% | 126% | 9/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 4.77% | -11.83% | -74.09% | 15/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 18.41% | 118.39% | 3.84% | 11/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 17.73% | 152.56% | 54.98% | 5/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 11.44% | 225% | 111.46% | 9/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.41% | 481.72% | -35.82% | 9/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.43% | 34.24% | 20.09% | 67/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.02% | 35.78% | 99.43% | 57/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 3.52% | -4.86% | 278.49% | 69/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.93% | -35.42% | -85.19% | 69/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 6.28% | -35.92% | 21.47% | 77/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 5.17% | -21.31% | 39.73% | 65/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 3.7% | -7.04% | 156.94% | 62/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.44% | -25% | -85.31% | 71/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 9.8% | -34.88% | 49.16% | 50/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.57% | -50.86% | 65.08% | 50/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 3.98% | -42.9% | 107.29% | 58/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.92% | -17.6% | -87.24% | 56/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 15.05% | -13.61% | 12.57% | 27/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 13.37% | 2% | 91.82% | 17/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 6.97% | 21.43% | -59.99% | 29/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 17.42% | -1.86% | 203.48% | 31/159 | 6.19% | 河化股份 | 54.24% | 行业排名> |
| 2016-06-30 | 5.74% | -35.36% | 146.35% | 36/159 | 3.48% | 华东医药 | 7.2% | 行业排名> |
| 2016-03-31 | 2.33% | 2% | -86.87% | 33/159 | 2.65% | 南新制药 | 81.7% | 行业排名> |
| 2015-12-31 | 17.75% | 1.08% | 99.89% | 25/159 | 11.27% | 德展健康 | 29.5% | 行业排名> |
| 2015-06-30 | 8.88% | 2% | -49.43% | 17/159 | 4.87% | 贝达药业 | 16.78% | 行业排名> |